Hostname: page-component-6898cfcb55-th4rj Total loading time: 0 Render date: 2026-11-11T10:04:43.010Z Has data issue: false hasContentIssue false

Baseline, Placebo, and Treatment: Efficient Estimation for Three-Group Experiments

Published online by Cambridge University Press:  04 January 2017

Alan S. Gerber*
Affiliation:
Institution for Social and Policy Studies and Department of Political Science, Yale University, 77 Prospect Street, New Haven, CT 06511
Donald P. Green
Affiliation:
Institution for Social and Policy Studies and Department of Political Science, Yale University, 77 Prospect Street, New Haven, CT 06511
Edward H. Kaplan
Affiliation:
School of Management, School of Public Health, and School of Engineering and Applied Science, Yale University, 135 Prospect Street, New Haven, CT 06511
Holger L. Kern
Affiliation:
Institution for Social and Policy Studies, Yale University, 77 Prospect Street, New Haven, CT 06511. From August 2010, Department of Political Science, University of South Carolina, 817 Henderson Street, Columbia, SC 29208
*
e-mail: alan.gerber@yale.edu (corresponding author)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Randomized experiments commonly compare subjects receiving a treatment to subjects receiving a placebo. An alternative design, frequently used in field experimentation, compares subjects assigned to an untreated baseline group to subjects assigned to a treatment group, adjusting statistically for the fact that some members of the treatment group may fail to receive the treatment. This article shows the potential advantages of a three-group design (baseline, placebo, and treatment). We present a maximum likelihood estimator of the treatment effect for this three-group design and illustrate its use with a field experiment that gauges the effect of prerecorded phone calls on voter turnout. The three-group design offers efficiency advantages over two-group designs while at the same time guarding against unanticipated placebo effects (which would undermine the placebo-treatment comparison) and unexpectedly low rates of compliance with the treatment assignment (which would undermine the baseline-treatment comparison).

Information

Type
Research Article
Copyright
Copyright © The Author 2010. Published by Oxford University Press on behalf of the Society for Political Methodology 
Supplementary material: PDF

Gerber et al. supplementary material

Appendix

Download Gerber et al. supplementary material(PDF)
PDF 193.8 KB